01 July 2005 : Original article
Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.
Helena Hruskovicová, Tomaz Milanez, Jan Kobal, Karmen Peterlin Potisk, Danijel Petrovic, Borut PeterlinMed Sci Monit 2005; 11(7): BR248-252 :: ID: 16977
Abstract
Background: It has been suggested that iron metabolism may be involvedin the pathogenesis of atherothrombotic cerebral infarction (ACI). The C282Y and H63D mutations in thehemochromatosis (HFE) gene are associated with increased serum iron levels and net iron accumulation.The aim of this study was to test the hypothesis that the C282Y and H63D mutations in the HFE gene arerisk factors for ACI in a Slovene population. Material/Methods: The C282Y and H63D HFE gene mutationswere tested in 96 Caucasian patients who had suffered an acute cerebral infarction, later confirmed asACI, and 115 control subjects. Genotypes were determined by electrophoresis of the DNA digestion productsfrom RsaI (C282Y) and MboI (H63D). Results: We failed to demonstrate that the C282Y and H63D mutationswere risk factors for ACI in Caucasians. The percentage of C282Y and H63D genotypes (dominant model)in ACI-cases (C282Y: 7.3%, n=7; H63D: 28.1%, n=27) did not differ significantly (P=0.9 and P=0.7 respectively)from that of the controls (C282Y: 7.0%, n=8; H63D: 26.1%, n=30). Logistic regression analysis revealedthat arterial hypertension, diabetes, and cigarette smoking are independent risk factors for ACI, whereasthe C282Y and H63D HFE gene mutations are not. Conclusions: We provided evidence that the C282Y and H63DHFE gene mutations were not risk factors for ACI in this Slovene population.
Keywords: Intracranial Arteriosclerosis - genetics, Intracranial Thrombosis - complications, Intracranial Thrombosis - genetics, Cerebral Infarction - genetics, Diabetes Complications, Hemochromatosis - genetics, Hypertension - complications, Intracranial Arteriosclerosis - genetics, Intracranial Thrombosis - genetics, Mutation, Risk Factors, Slovenia, Smoking - adverse effects
Editorial
01 October 2024 : Editorial
Editorial: Potentials and Pitfalls in Targeting Glucagon-Like Peptide-1 (GLP-1) in the Management of Increasing Levels of ObesityDOI: 10.12659/MSM.946675
Med Sci Monit 2024; 30:e946675
In Press
Clinical Research
Anterior Disc Displacement and Cortication Patterns in the Temporomandibular JointMed Sci Monit In Press; DOI: 10.12659/MSM.945967
Review article
Lamotrigine: A Safe and Effective Mood Stabilizer for Bipolar Disorder in Reproductive-Age AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.945464
Clinical Research
Impact of Manual Sustained Inflation vs Stepwise PEEP on Pulmonary and Cerebral Outcomes in Carotid Endarte...Med Sci Monit In Press; DOI: 10.12659/MSM.944936
Clinical Research
Predicting Vaginal Delivery Success: Role of Intrapartum Transperineal Ultrasound Angle of Descent at a Sin...Med Sci Monit In Press; DOI: 10.12659/MSM.945458
Most Viewed Current Articles
17 Jan 2024 : Review article 6,056,505
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,846,289
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 693,590
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 257,892
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074